209 related articles for article (PubMed ID: 16320335)
1. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes.
Wolfe F; Michaud K; Pincus T; Furst D; Keystone E
Arthritis Rheum; 2005 Dec; 52(12):3873-9. PubMed ID: 16320335
[TBL] [Abstract][Full Text] [Related]
2. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
3. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
[TBL] [Abstract][Full Text] [Related]
4. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K
Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487
[TBL] [Abstract][Full Text] [Related]
5. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
Keystone E; Freundlich B; Schiff M; Li J; Hooper M
J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
[TBL] [Abstract][Full Text] [Related]
6. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
7. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
8. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
[TBL] [Abstract][Full Text] [Related]
9. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
Lee SJ; Chang H; Yazici Y; Greenberg JD; Kremer JM; Kavanaugh A
J Rheumatol; 2009 Aug; 36(8):1611-7. PubMed ID: 19369454
[TBL] [Abstract][Full Text] [Related]
10. Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centres.
Smith N; Gadsby K; Butt S; Carruthers D; Deeming A; Ledingham J; Fletcher M; Mulherin D; Roskell S; Kay L; Nicholl K; Cooper R; Worsley A; Deighton C
Rheumatology (Oxford); 2007 Oct; 46(10):1557-9. PubMed ID: 17666440
[TBL] [Abstract][Full Text] [Related]
11. Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort.
Kahn KL; Maclean CH; Wong AL; Rubenstein LZ; Liu H; Fitzpatrick DM; Harker JO; Chen WP; Traina SB; Mittman BS; Hahn BH; Paulus HE
Arthritis Rheum; 2007 Jun; 57(5):707-15. PubMed ID: 17530663
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
Genevay S; Finckh A; Ciurea A; Chamot AM; Kyburz D; Gabay C;
Arthritis Rheum; 2007 May; 57(4):679-85. PubMed ID: 17471545
[TBL] [Abstract][Full Text] [Related]
13. The composite DAS Score is impractical to use in daily practice: evidence that physicians use the objective component of the DAS in decision making.
Lindsay K; Ibrahim G; Sokoll K; Tripathi M; Melsom RD; Helliwell PS
J Clin Rheumatol; 2009 Aug; 15(5):223-5. PubMed ID: 19590441
[TBL] [Abstract][Full Text] [Related]
14. Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure.
Wolfe F; Michaud K
J Rheumatol; 2009 Jan; 36(1):27-33. PubMed ID: 19040313
[TBL] [Abstract][Full Text] [Related]
15. Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis.
Benito-Garcia E; Heller JE; Chibnik LB; Maher NE; Matthews HM; Bilics JA; Weinblatt ME; Shadick NA
J Rheumatol; 2006 Jul; 33(7):1275-81. PubMed ID: 16821266
[TBL] [Abstract][Full Text] [Related]
16. Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-alpha inhibitors in adults with rheumatoid arthritis.
Greenwood MC; Rathi J; Hakim AJ; Scott DL; Doyle DV
Rheumatology (Oxford); 2007 Jul; 46(7):1165-7. PubMed ID: 17488751
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
Wolfe F; Pincus T; O'Dell J
J Rheumatol; 2001 Jul; 28(7):1712-7. PubMed ID: 11469486
[TBL] [Abstract][Full Text] [Related]
18. Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales.
Wolfe F; Michaud K; Li T
J Rheumatol; 2006 Oct; 33(10):1942-51. PubMed ID: 16960928
[TBL] [Abstract][Full Text] [Related]
19. Health literacy predicts the discrepancy between patient and provider global assessments of rheumatoid arthritis activity at a public urban rheumatology clinic.
Hirsh JM; Boyle DJ; Collier DH; Oxenfeld AJ; Caplan L
J Rheumatol; 2010 May; 37(5):961-6. PubMed ID: 20231210
[TBL] [Abstract][Full Text] [Related]
20. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
Yazici Y; Bergman M; Pincus T
J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
